Gene variant may increase risk for suicide
People who are coping with diseases such as schizophrenia or bipolar disorder can attempt to live a functional life if they buy Canadian Zyprexa at a fraction of the cost.
People who are coping with diseases such as schizophrenia or bipolar disorder can attempt to live a functional life if they buy Canadian Zyprexa at a fraction of the cost. The appropriate treatments for these conditions can help patients avoid debilitating symptoms, including delusions or thoughts of suicide. A recent study examining the genes of patients like these uncovered a variant that may make someone more likely to commit suicide, opening the door to potential new treatments.
Past research has suggested that one form of the gene for brain-derived neurotrophic factor may increase people's risk for suicide when compared to another form of the gene. A new meta-study that looked at findings based on more than 3,300 subjects - encompassing 11 past experiments that included more than 1,200 individuals with a history of suicidal behavior - adds to that growing body of evidence, as reported in the International Journal of Neuropsychopharmacology. Patients had mental illnesses such as schizophrenia or some type of mood disorder.
"Our findings may lead to the testing and development of treatments that target this gene in order to help prevent suicide," said author James Kennedy. "In the future, if other researchers can replicate and extend our findings, then genetic testing may be possible to help identify people at increased risk for suicide."
|
